This research emerges from the need to shed light on the ongoing debate about vaccine passport policies for dealing with COVID-19. We analyze the way two essential airline stakeholders assess vaccine passports: investors—for whom the following question is posed: Is the implementation of vaccine passports positively evaluated by airline investors?—and passengers, for whom the question to be examined is To which extent do vaccine passports help in reducing perceived health risks?

Read More